Physician Quick Search
By Name:
By Specialty:
When you need to get the name of one of the nation’s top doctors as close to home as St. Louis, just call 314-TOP-DOCS (314-867-3627) or toll free 1-866-867-3627. This is the physician referral and health information line from Barnes-Jewish Hospital.
Your Healthy Update

Like us on Facebook
Text Size: S M L

Internal Medicine / Infectious Diseases

Erik Richard Dubberke, MD

Current Position
Associate Professor, Medicine
Division of Infectious Diseases

Specialty Areas
Infectious Diseases

Patients Seen At
Storz Building
4570 Children's Place
St. Louis, MO  63110
Fax:   314-222-6252
View Driving Directions

Mailing Address
Washington University School of Medicine
Division of Infectious Diseases
660 South Euclid Avenue, Campus Box 8051
St. Louis, MO  63110

Areas of Clinical Interest
Infectious diseases, C. difficile infection, fungal infections, infections in transplant patients,  infections in cancer patients

Areas of Research Interest
Clostridium-difficile infection, infections in transplant and oncology patients

Board Certification
Internal Medicine -- Certified
Infectious Diseases -- Certified

Medical Education
B.A.: Augustana College, Rock Island, Illinois, 1995
Medical Degree: University of Illinois at Chicago College of Medicine, Rockford, Illinois, 1999
Residency: Washington University School of Medicine, St. Louis, Missouri, 2002
Hospital Affiliations
Barnes-Jewish Hospital
John Cochran VA Hospital

Honors and Awards
Alpha Omega Alpha
Phi Beta Kappa
Trainee Award, Society for Healthcare Epidemiology of America

Disclosure of Financial Interests with Industry
Washington University and its physicians are committed to ensuring integrity and objectivity in medical decision-making. Some of our physicians work collaboratively with pharmaceutical or medical device companies to develop innovative ideas and products that can improve health care delivery and clinical outcomes for patients. In some instances, our faculty physicians are paid by these commercial companies to provide advice on product design or to speak about the use of medications, devices, equipment or procedures. These payments may include: a) compensation for consulting and speaking engagements, b) equity, and/or c) royalties for products invented by our faculty. Any payments to Washington University physicians must be based on tangible services and may not exceed fair market value for their work. In addition to disclosure on this web site, physicians earning more than $10,000 per year must disclose their corporate financial relationship in writing to patients when prescribing or using that company's products.

Dr. Erik Richard Dubberke reported the following earned financial interests during calendar year 2014. Move your mouse over a header for more info.
Royalties: When a faculty member invents or conceives a new or improved process or product, the company that manufactures the product will make royalty payments to the faculty member. Royalty payments usually are a small percentage of the company’s revenue related to that product.
Consulting &
Advisory Boards
Consulting and Advisory Boards: Faculty may be paid to provide expertise to a company by being their consultant, or by serving on an advisory board.
Speaker Fees
Speaker Fees: Companies may pay faculty to speak to professional audiences about their products.
Merck  $10,001-$25,000  
To learn more about Washington University's policies on collaborations with industry, click here.

Editorial Responsibilities
Bone Marrow Transplantation
Clinical Infectious Diseases
Infection Control and Hospital Epidemiology
Intensive Care Medicine
Journal of the American Medical Association

Selected or Recent Journal Articles
Honda H, Dubberke ER. The changing epidemiology of Clostridium difficile infection. Curr Opin Gastroenterol. 2013 Nov 26. [Epub ahead of print]

Dubberke ER, Burdette SD; AST Infectious Diseases Community of Practice. Clostridium difficile infections in solid organ transplantation. Am J Transplant. 2013 Mar;13 Suppl 4:42-9.

Bobo LD, El Feghaly RE, Chen YS, Dubberke ER, Han Z, Baker AH, Li J, Burnham CA, Haslam DB. MAPK-activated protein kinase 2 contributes to Clostridium difficile-associated inflammation. Infect Immun. 2013 Mar;81(3):713-22.

Hink T, Burnham CA, Dubberke ER. A systematic evaluation of methods to optimize culture-based recovery of Clostridium difficile from stool specimens. Anaerobe. 2013 Feb;19:39-43.

Westblade LF, Chamberland RR, MacCannell D, Collins R, Dubberke ER, Dunne WM Jr, Burnham CA. Development and evaluation of a novel, semiautomated Clostridium difficile typing platform. J Clin Microbiol. 2013 Feb;51(2):621-4.

Dubberke ER, Olsen MA. Burden of Clostridium difficile on the healthcare system. Clin Infect Dis. 2012 Aug.

Kasper AM, Nyazee HA, Yokoe DS, Mayer J, Mangino JE, Khan YM, Hota B, Fraser VJ, Dubberke ER; Centers for Disease Control and Prevention Epicenters Program. A multicenter study of Clostridium difficile infection-related colectomy, 2000-2006. Infect Control Hosp Epidemiol. 2012 May.

Dubberke E. Strategies for prevention of Clostridium difficile infection. J Hosp Med. 2012 Mar.

Dubberke E. Clostridium difficile infection: the scope of the problem. J Hosp Med. 2012 Mar.

Dubberke ER, Nyazee HA, Yokoe DS, Mayer J, Stevenson KB, Mangino JE, Khan YM, Fraser VJ. Implementing automated surveillance for tracking Clostridium difficile infection at multiple healthcare facilities.  Infect Control Hosp Epidemiol. 2012 Mar.

Han Z, McMullen KM, Russo AJ, Copper SM, Warren DK, Dubberke ER. A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes. Am J Infect Control. 2012 May;40(4):349-53. Epub 2011 Jul 27.

Dubberke ER, Han Z, Bobo L, Hink T, Lawrence B, Copper S, Hoppe-Bauer J, Burnham CA, Dunne WM Jr. Impact of clinical symptoms on interpretation of diagnostic assays for Clostridium difficile infections. J Clin Microbiol. 2011 Aug.

Dubberke ER, Butler AM, Nyazee HA, Reske KA, Yokoe DS, Mayer J, Mangino JE, Khan YM, Fraser VJ; Centers for Disease Control and Prevention Epicenters Program. The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections. Clin Infect Dis. 2011 Jul 1.

Dubberke ER, Yan Y, Reske KA, Butler AM, Doherty J, Pham V, Fraser VJ. Development and validation of a Clostridium difficile infection risk prediction model. Infect Control Hosp Epidemiol. 2011 Apr.

Dubberke ER, Haslam DB, Lanzas C, Bobo LD, Burnham CA, Gröhn YT, Tarr PI. The ecology and pathobiology of Clostridium difficile infections: an interdisciplinary challenge. Zoonoses Public Health. 2011 Feb.

For more articles and abstracts, take this off-site link to the National Library of Medicine Pub Med page for Dr. Erik Dubberke.

Washington University Physicians are the medical staff of  Barnes-Jewish Hospital and Children's Hospital - St. Louis Employment   About Us   Top Stories   For Your Protection      Site Map
Copyright 2015 Washington University School of Medicine
Copyright 2015 Washington University School of Medicine